Log in

TSE:CRHCRH Medical Stock Price, Forecast & News

C$3.02
-0.03 (-0.98 %)
(As of 07/10/2020 08:53 AM ET)
Add
Compare
Today's Range
C$2.89
Now: C$3.02
C$3.06
50-Day Range
C$2.55
MA: C$2.97
C$3.77
52-Week Range
C$1.26
Now: C$3.02
C$5.90
Volume200,319 shs
Average Volume182,019 shs
Market CapitalizationC$216.12 million
P/E Ratio127.08
Dividend YieldN/A
BetaN/A
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Read More
CRH Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-6331440

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$116.72 million
Cash FlowC$0.18 per share
Book ValueC$1.05 per share

Profitability

Miscellaneous

Employees112
Market CapC$216.12 million
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive CRH News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH and its competitors with MarketBeat's FREE daily newsletter.

CRH Medical (TSE:CRH) Frequently Asked Questions

How has CRH Medical's stock been impacted by COVID-19 (Coronavirus)?

CRH Medical's stock was trading at C$3.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRH stock has decreased by 22.0% and is now trading at C$3.02. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CRH Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CRH Medical.

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for CRH Medical.

How were CRH Medical's earnings last quarter?

CRH Medical Corp (TSE:CRH) posted its earnings results on Tuesday, May, 12th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $34.17 million for the quarter, compared to the consensus estimate of $40.04 million. View CRH Medical's earnings history.

What price target have analysts set for CRH?

4 brokerages have issued 1-year target prices for CRH Medical's stock. Their forecasts range from C$4.00 to C$4.75. On average, they expect CRH Medical's share price to reach C$4.38 in the next twelve months. This suggests a possible upside of 44.9% from the stock's current price. View analysts' price targets for CRH Medical.

Has CRH Medical been receiving favorable news coverage?

Headlines about CRH stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CRH Medical earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about CRH Medical.

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRHM), Trican Well Service (TCW), Aurora Cannabis (ACB), Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Journey Energy (JOY), DHX Media (DHX.B), ProMetic Life Sciences (PLI), Medical Facilities (DR) and Enerplus (ERF).

Who are CRH Medical's key executives?

CRH Medical's management team includes the following people:
  • Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
  • Mr. James Kreger, Pres of CRH Anesthesia Management
  • Ms. Kettina Cordero, Director of Investor Relations

What is CRH Medical's stock symbol?

CRH Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRH."

How do I buy shares of CRH Medical?

Shares of CRH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRH stock can currently be purchased for approximately C$3.02.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of C$216.12 million and generates C$116.72 million in revenue each year. CRH Medical employs 112 workers across the globe.

What is CRH Medical's official website?

The official website for CRH Medical is investors.crhsystem.com.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.